Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 155 citing articles:

CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022
Deborah Dowell, Kathleen Ragan, Christopher M. Jones, et al.
MMWR Recommendations and Reports (2022) Vol. 71, Iss. 3, pp. 1-95
Open Access | Times Cited: 951
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Thomas Santo, Brodie Clark, Matthew Hickman, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 9, pp. 979-979
Open Access | Times Cited: 380
Cost-effectiveness of Treatments for Opioid Use Disorder
Michael Fairley, Keith Humphreys, Vilija R. Joyce, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 7, pp. 767-767
Open Access | Times Cited: 110
The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study
Theresa Winhusen, Alexander Y. Walley, Laura Fanucchi, et al.
Drug and Alcohol Dependence (2020) Vol. 217, pp. 108325-108325
Open Access | Times Cited: 91
Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation
Tara Gomes, Tonya Campbell, Sophie A. Kitchen, et al.
JAMA (2022) Vol. 327, Iss. 9, pp. 846-846
Open Access | Times Cited: 69
Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association
Larry M. Baddour, Melissa B. Weimer, Alysse G. Wurcel, et al.
Circulation (2022) Vol. 146, Iss. 14
Open Access | Times Cited: 63
Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study
Heather Palis, Chloé G. Xavier, Sabina Dobrer, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study
Andrew McAuley, Rosalyn Fraser, Megan Glancy, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 7, pp. e484-e493
Open Access | Times Cited: 33
Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit
Scott G. Weiner, Kacey Little, Jiah Yoo, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2423954-e2423954
Open Access | Times Cited: 10
Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada
Samantha Young, Nadia Fairbairn, Zishan Cui, et al.
Addiction (2025)
Open Access | Times Cited: 1
Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol
Bohdan Nosyk, Amanda Slaunwhite, Karen Urbanoski, et al.
BMJ Open (2021) Vol. 11, Iss. 6, pp. e048353-e048353
Open Access | Times Cited: 45
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder
Brendan Jacka, Tim Janssen, Bryan R. Garner, et al.
Drug and Alcohol Dependence (2021) Vol. 221, pp. 108617-108617
Open Access | Times Cited: 44
Periods of altered risk for non-fatal drug overdose: a self-controlled case series
Claire Keen, Stuart A. Kinner, Jesse T Young, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 4, pp. e249-e259
Open Access | Times Cited: 42
A systematic review of menstrual hygiene management (MHM) during humanitarian crises and/or emergencies in low- and middle-income countries
Kripalini Patel, Nishisipa Panda, Krushna Chandra Sahoo, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 37
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada
Samantha Young, Gillian Kolla, Daniel McCormack, et al.
International Journal of Drug Policy (2022) Vol. 102, pp. 103601-103601
Open Access | Times Cited: 35
Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality
Bradley V. Watts, Daniel J. Gottlieb, Natalie Riblet, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 4, pp. 298-304
Closed Access | Times Cited: 32
Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder
Bohdan Nosyk, Jeong Eun Min, Fahmida Homayra, et al.
JAMA (2024)
Closed Access | Times Cited: 8
Harm Reduction in the Field: First Responders’ Perceptions of Opioid Overdose Interventions
Callan Fockele, Tessa Frohe, Owen McBride, et al.
Western Journal of Emergency Medicine (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 6
Rapid Implementation of Telehealth in Hospital Psychiatry in Response to COVID-19
Marc Kalin, Steven J. Garlow, Ketty Thertus, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 7, pp. 636-637
Closed Access | Times Cited: 49
Risk of overdose‐related death for people with a history of incarceration
Wen Qi Gan, Stuart A. Kinner, Tonia L. Nicholls, et al.
Addiction (2020) Vol. 116, Iss. 6, pp. 1460-1471
Open Access | Times Cited: 45
A systematic literature review of clinical trials and therapeutic applications of ibogaine
Patrick Köck, Katharina Froelich, Marc Walter, et al.
Journal of Substance Abuse Treatment (2021) Vol. 138, pp. 108717-108717
Open Access | Times Cited: 34
Disparities in Receipt of Medications for Opioid use Disorder among Pregnant Women
Laura E. Henkhaus, Melinda Beeuwkes Buntin, Sarah C. Henderson, et al.
Substance Abuse (2021) Vol. 43, Iss. 1, pp. 508-513
Open Access | Times Cited: 33
Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials
Jihoon Lim, Imen Farhat, Antonios Douros, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0266142-e0266142
Open Access | Times Cited: 27
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency
Marion Selfridge, Kiffer G. Card, Taylor Kandler, et al.
International Journal of Drug Policy (2022) Vol. 105, pp. 103709-103709
Open Access | Times Cited: 25
Efficacy of Analgesic Propofol/Esketamine and Propofol/Fentanyl for Painless Induced Abortion: A Randomized Clinical Trial
Naixing Xin, Wei Yan, Shuangfen Jin
BioMed Research International (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top